Rotavirus Vaccine Administration Errors — United States, 2006–2013

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Hibbs, Beth F. ; Miller, Elaine R. ; Shimabukuro, Tom T.
• Description:
  Two live rotaVirus oral vaccines, RotaTeq (RV5) (Merck & Co., Inc.) and Rotarix (RV1) (GlaxoSmithKline Biologicals), are approved for Prevention of rotaVirus gastroenteritis and recommended at ages 2, 4 (RV5/RV1), and 6 (RV5) months by the Advisory Committee on Immunization Practices. Because most childhood vaccines are injectable, vaccination providers might have less experience administering oral vaccines. To assess that hypothesis, CDC searched for reports to the Vaccine Adverse Event Reporting System (VAERS) of rotaVirus vaccine administration errors involving injection and eye splashes in the United States during the period January 1, 2006-August 1, 2013. A total of 66 reports were found.
• Subjects:
  Administration, Oral Adverse Drug Reaction Reporting Systems Eye Injuries Humans Infant Injections Medical Errors Notes From The Field RotaVirus Infections RotaVirus Vaccines Vaccines, Live, Unattenuated

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 2014; 63(4):81.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  24476980
• Pubmed Central ID:
  PMC4584899
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  63
• Issue:
  4
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:9392212e90d8b3fdfedb8c147d3c6e6c6f7eced3fad3466cc457e3f67bd5dabd9d92230fe816947b840b96415bc0c971a29e3a19f5cfc344a6b6ab6d5fdc4444
• Download URL:
  https://stacks.cdc.gov/view/cdc/54851/cdc_54851_DS1.pdf
• File Type:
  [PDF - 118.30 KB ]